A Cost-Effectiveness Analyses of Using Sunitinib (SU) in First Line of Metastatic Renal Cancer in Romanian Jurisdiction
Nov 1, 2013, 00:00
10.1016/j.jval.2013.08.509
https://www.valueinhealthjournal.com/article/S1098-3015(13)02414-5/fulltext
Title :
A Cost-Effectiveness Analyses of Using Sunitinib (SU) in First Line of Metastatic Renal Cancer in Romanian Jurisdiction
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(13)02414-5&doi=10.1016/j.jval.2013.08.509
First page :
A411
Section Title :
Disease-Specific Studies
Open access? :
No
Section Order :
488